Tower Research Capital (TRC)’s AvePoint AVPT Stock Holding History
Bought
Maintained
Sold
Other funds holding AVPT
A6
PCM
Tower Research Capital (TRC)'s AVPT Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its AvePoint (AVPT) stake by 22% in Q2 2026, buying an estimated $43.3K and bringing the position to 23,567 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #1488.
Tower Research Capital (TRC) first reported a position in AVPT in Q2 2020 and has held it in 23 quarters since. The position peaked at $288K in Q2 2025. 253 funds tracked by Wall St. Rank hold AVPT as of Q2 2026.
- Tower Research Capital (TRC) held 23,567 shares of AvePoint worth $264K as of Q2 2026.
- Tower Research Capital (TRC) bought 4,211 AvePoint shares in Q2 2026, an estimated $43.3K.
- AvePoint made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1488 holding.
- Tower Research Capital (TRC) first reported a position in AvePoint in Q2 2020 and has held it in 23 quarters since.
- Tower Research Capital (TRC)'s AvePoint position peaked at $288K in Q2 2025.
- 253 funds tracked by Wall St. Rank held AvePoint as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.